All News2024
- Apr. 25, 2024 Corporate[Notice] New True to Life story featured “C-TEC” the Endoscopy Training Center is now launched
- Apr. 22, 2024 Corporate[Notice] Odin Vision Leveraged NVIDIA Inception Program for Startups to Build Cloud-Connected AI Models to Support Endoscopy
- Apr. 19, 2024 Corporate[Notice] New Installment in True to Life Story Series Features Olympus Korea Corporate Social Responsibility Initiative “Going on Campaign”
- Apr. 12, 2024 Corporate[Notice] Launch of a New Story in the True to Life Series Featuring a Patient Diagnosed with Colorectal Cancer at 33
- Apr. 12, 2024 Corporate[Notice] Olympus Sponsors the Signature Pavilion "null2" of the 2025 World Exposition (Expo 2025 Osaka, Kansai, Japan)
-
Apr. 08, 2024
IRNotice Concerning the start of the process to return certain land and building in Shenzhen
- Apr. 03, 2024 MedicalOlympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
-
Mar. 28, 2024
IR(Progress of disclosure matters) Notice Concerning the Impact of the 2024 Noto Peninsula Earthquake
-
Mar. 28, 2024
IRNotification for the Candidates for the Board of Directors
- Mar. 27, 2024 CorporateNTT and Olympus Begin World’s First Joint Demonstration Experiment of Cloud Endoscopy System
-
Mar. 26, 2024
IRNotice Regarding Completion of Share Repurchase and Cancellation of Treasury Shares
- Mar. 25, 2024 Corporate[Notice] Olympus Wins Award for Excellence at the Third Nikkei Integrated Report Awards
- Mar. 11, 2024 CorporateOlympus Certified as a 2024 White 500 Company for Outstanding Health and Productivity Management
-
Mar. 08, 2024
IRNotice Regarding Rescission of Definitive Agreement to Acquire shares of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd.
- Mar. 08, 2024 Corporate[Notice] New True to Life story “Dr. Bala’s Challenge” is now launched
- Mar. 06, 2024 CorporateOlympus Certified as a 2024 Sports Yell Company by the Japan Sports Agency
-
Mar. 04, 2024
IRNotice Regarding Status of Share Repurchase
-
Mar. 01, 2024
IR(Progress of disclosure matters) Notice Concerning the Impact of the 2024 Noto Peninsula Earthquake
- Feb. 14, 2024 IRThird Quarter Financial Results
-
Feb. 14, 2024
IRNotice Concerning the Revision of Financial Forecast
-
Feb. 09, 2024
IRNotice Concerning the Impact of the 2024 Noto Peninsula Earthquake
- Feb. 06, 2024 Corporate[Notice] Elevating Culture: Olympus Unveils New Core Values Aligned to Global MedTech Leadership
-
Feb. 02, 2024
IRNotice Regarding Status of Share Repurchase
-
Jan. 31, 2024
IRNotice Concerning Change of Executive Officers
- Jan. 31, 2024 CorporateOlympus Announces Changes to Executive Officer Positions
-
Jan. 25, 2024
IR(Updated) (Progress of disclosure matters) Notice Regarding Completion of Acquisition of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd. (to make it a subsidiary)
-
Jan. 24, 2024
IR(Progress of disclosure matters) Notice Regarding Completion of Acquisition of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd. (to make it a subsidiary)
- Jan. 24, 2024 CorporateOlympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd,
- Jan. 15, 2024 CorporateCanon Medical Systems and Olympus Announce Business Alliance regarding Endoscopic Ultrasound Systems
- Jan. 11, 2024 CorporateOlympus Creates a Work Environment that Promotes Autonomous Work and Work-Life Balance
- Jan. 10, 2024 CorporateOlympus Donates for the 2024 Noto Peninsula Earthquake Relief
-
Jan. 05, 2024
IRNotice Regarding Status of Share Repurchase